ESR2 and cancer: ERα is associated with aberrant proliferation, inflammation and development of malignancy whereas ERβ opposes ERα mediated cell proliferation by modulating the expression of many ERα-regulated genes and exhibiting anti-migratory and anti-invasive properties in cancer cells (Thomas and Gustafsson, 2011).